NCT07414576 AI-driven Total Parenteral Nutrition Platform
| NCT ID | NCT07414576 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Takeoff41, Inc. |
| Condition | Intestinal Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 260 participants |
| Start Date | 2026-01-21 |
| Primary Completion | 2027-02-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 260 participants in total. It began in 2026-01-21 with a primary completion date of 2027-02-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study tests whether an artificial intelligence (AI) tool can help doctors order total parenteral nutrition (TPN) for babies in the neonatal intensive care unit (NICU). Premature babies often cannot eat by mouth and need nutrition delivered through an IV. Ordering TPN is complex, time-consuming, and mistakes can happen. This study will test an AI tool that suggests TPN formulas to doctors based on each baby's lab values and health information. Doctors can accept, change, or reject the suggestions at any time. The main goal is to measure how often doctors accept the AI suggestions. The study will also track time to complete TPN orders, weight changes, days on TPN, whether lab values stay in normal ranges, provider satisfaction, and baby health outcomes including complications such as lung disease, brain bleeding, infections, and other conditions common in premature babies. Babies admitted to the NICU who need TPN may participate if their doctors agree to use the tool. Each baby will be in the study while they need TPN, typically about 14 days. The AI tool only makes suggestions and does not replace doctor decision-making. All other care remains the same as standard practice.
Eligibility Criteria
Inclusion Criteria: * Any newborns or infants requiring total parenteral nutrition in a neonatal ICU that performs daily laboratory tests * 6-month old at the time of admission * Any gestational age or birthweight * Any race or sex Exclusion Criteria: \- Infants deem unfit for the suggested TPN due to safety concerns by physicians
Contact & Investigator
David Stevenson, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT07414576 clinical trial?
This trial is open to participants of all sexes, up to 6 Months, studying Intestinal Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07414576 currently recruiting?
Yes, NCT07414576 is actively recruiting participants. Contact the research team at joe@takeoff41.com for enrollment information.
Where is the NCT07414576 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT07414576 clinical trial?
NCT07414576 is sponsored by Takeoff41, Inc.. The principal investigator is David Stevenson, MD at Stanford University. The trial plans to enroll 260 participants.